Shenzhen Lifotronic Technology Co - Asset Resilience Ratio

Latest as of December 2024: 2.53%

Shenzhen Lifotronic Technology Co (688389) has an Asset Resilience Ratio of 2.53% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shenzhen Lifotronic Technology Co working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥73.25 Million

≈ $10.72 Million USD Cash + Short-term Investments

Total Assets

CN¥2.89 Billion

≈ $423.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Shenzhen Lifotronic Technology Co's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shenzhen Lifotronic Technology Co total assets.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Lifotronic Technology Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Shenzhen Lifotronic Technology Co debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥73.25 Million	2.53%
Total Liquid Assets	CN¥73.25 Million	2.53%

Asset Resilience Insights

Limited Liquidity: Shenzhen Lifotronic Technology Co maintains only 2.53% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Lifotronic Technology Co Industry Peers by Asset Resilience Ratio

Compare Shenzhen Lifotronic Technology Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Shenzhen Lifotronic Technology Co (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Lifotronic Technology Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.53%	CN¥73.25 Million ≈ $10.72 Million	CN¥2.89 Billion ≈ $423.56 Million	--

pp = percentage points

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices

Market Cap

$697.86 Million

CN¥4.77 Billion CNY

Market Cap Rank

#10731 Global

#2961 in China

Share Price

CN¥11.13

Change (1 day)

+1.09%

52-Week Range

CN¥9.59 - CN¥14.74

All Time High

CN¥37.22